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Background
Allergy is a critical problem of public health in devel-
oped countries. Anaphylaxis is a rapid allergic response
with symptoms such as urticarial, itching, diarrhea, and
even death. Since allergy is caused by the failure of tol-
erance induction to exogenous antigens, its establish-
ment of tolerance is a fundamental therapy for allergic
diseases. Oral tolerance is a physiological way to actively
induce unresponsiveness to food antigens. However, oral
immunotherapy using antigens occasionally fails to
induce complete tolerance in patients that hinder the
development of the therapy.
Methods
To clarify the mechanism of the induction of allergy and
oral tolerance, we have established a protocol with rush
administration of oral antigen and evaluated how ana-
phylaxis is suppressed.
Results
Using this rush specific oral tolerance induction (Rush-
SOTI) protocol, we found that the drop of body tem-
perature was partially blocked and recovery was acceler-
ated. Antigen-specific IgE was not reduced by Rush-
SOTI. Antagonists of both histamine and platelet-acti-
vating factor (PAF) completely prevented the drop of
body temperature in anaphylactic mice. From the
kinetics, it is suggested that histamine acts in the early
phase while PAF functions in the late phase.We further
analyze the cell population involved in the temperature
drop. Depletion of Gr-1+ neutrophils but not mast cells
partially prevent body temperature drop. Significant
reduction of inflammatory cytokines was correlated to
this effect.
Conclusion
Together with the observation that he kinetics in both
mice with Gr-1+ Cell-depletion and Rush-SOTI treat-
ment were similar, it is suggested that Rush-SOTI pre-
vents anaphylaxis by controlling PAF metabolism, and
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